<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03607695</url>
  </required_header>
  <id_info>
    <org_study_id>E2553-P</org_study_id>
    <secondary_id>I21RX002553-01</secondary_id>
    <nct_id>NCT03607695</nct_id>
  </id_info>
  <brief_title>Genetic Influences on Response to Gait Rehabilitation in Parkinson's Disease</brief_title>
  <acronym>Gen-Ex</acronym>
  <official_title>Genetic Influences on Response to Gait Rehabilitation in Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aging Veteran population, together with high exposure to Agent Orange or other herbicides&#xD;
      during military service, has made diseases such as Parkinson's disease (PD), currently&#xD;
      affecting more than 80,000 Veterans, a major health issue in the Veterans' health system.&#xD;
      Mobility and cognitive limitations are a common problem in PD and are associated with&#xD;
      significant disability, increased fall risk, reduced quality of life, and increased caregiver&#xD;
      burden. While less is known about its benefit on cognition, physical therapy has proven to be&#xD;
      an effective treatment to mitigate mobility limitations, though the response to&#xD;
      rehabilitation interventions is highly variable. The proposed research will inform the&#xD;
      investigators' understanding of the impact of certain genetic profiles associated with&#xD;
      learning impairments on motor and cognitive benefits in response to gait rehabilitation, and&#xD;
      will provide an important foundation for more personalized and improved gait rehabilitation&#xD;
      programs for different subgroups of PD patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The completion of the Human Genome Project in 2003 marked the beginning of the genomic era&#xD;
      and the birth of &quot;personalized&quot; (precision) medicine. In the last decade, genetics have&#xD;
      provided a new understanding of predicting, diagnosing, and treating individual health&#xD;
      conditions. Indeed, such precision medicine has begun to impact virtually all areas of&#xD;
      medicine, with significant potential to influence the timing, dosage, and intensity of&#xD;
      physical rehabilitation.&#xD;
&#xD;
      The long-term goals of this research are: (1) to determine if certain genetic variants&#xD;
      associated to learning impairments impact the motor and cognitive benefit experienced in&#xD;
      response to physical rehabilitation in Veterans with Parkinson's disease (PD), and (2) to use&#xD;
      that knowledge to identify subpopulations of patients that may require rehabilitative&#xD;
      strategies tailored to their genotype to optimize physical rehabilitation. To achieve these&#xD;
      goals the investigators will enroll 30 Veterans with PD in a 10-week moderate intensity gait&#xD;
      training program consisting of 2 times per week treadmill training with verbal cues for gait&#xD;
      quality. Aim 1 will examine the association between variants in 2 genes known to affect&#xD;
      cognition and motor learning (APOE- 4 and BDNF-Met66), and motor improvements after gait&#xD;
      training. Specifically, changes in walking from during and after training will be sensitively&#xD;
      and objectively assessed using state-of-the-art quantitative gait analysis, and compared&#xD;
      between three genotype groups (carriers of BDNF-Met66 (N=10), carriers of APOE- 4 (N=10) and&#xD;
      those not carrying either of those variants (N=10)). Aim 2 will examine the effect of APOE- 4&#xD;
      and BDNF-Met66 genetic variants on cognitive changes in response to this training program. In&#xD;
      order to do this the investigators will measure cognitive performance pre- and post-training&#xD;
      using a brief, targeted battery aimed at assessing attention, processing speed, executive&#xD;
      function, and learning/memory, the domains more affected, and more likely to improve with&#xD;
      physical exercise in PD. The investigators will test the hypothesis that Veterans with PD who&#xD;
      carry an APOE- 4 or BDNF-Met66 allele will demonstrate smaller improvements in gait (Aim 1)&#xD;
      and cognition (Aim 2) in response to a 10-week gait training program. Overall the results of&#xD;
      this project will enhance the investigators' knowledge regarding the influence of different&#xD;
      genetic profiles in the response to physical rehabilitation in Veterans with PD, and will&#xD;
      generate supporting data that will translate to more personalized and effective&#xD;
      rehabilitation programs for people with PD.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2018</start_date>
  <completion_date type="Actual">June 30, 2020</completion_date>
  <primary_completion_date type="Actual">June 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>The intervention is a 10-week gait, treadmill-training program. The sessions are 1 hour long, twice a week.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gait Speed (m/s)</measure>
    <time_frame>measured at baseline, 2 weeks, 10 weeks and 16 weeks</time_frame>
    <description>The investigators will use the APDM Movement Monitoring system to assess gait speed (m/s) during straight-line walking as a measure of gait function.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Montreal Cognitive Assessment Score</measure>
    <time_frame>measured at baseline and at 10 weeks</time_frame>
    <description>The investigators will use the Montreal Cognitive Assessment (MoCA; score range=0-30, with 30 indicating better cognitive function) as a reflection of global cognitive function</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Parkinson's Disease</condition>
  <arm_group>
    <arm_group_label>Gait training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 hour walking exercise on a treadmill</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Gait training</intervention_name>
    <description>Walking on a treadmill and receiving audio cues to improve gait</description>
    <arm_group_label>Gait training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Meet UK Brain Bank (UKBB) criteria for the diagnosis of PD (modified so that having&#xD;
             more than one affected relative was not considered an exclusion criteria)&#xD;
&#xD;
          -  Have a Hoehn &amp; Yahr score of 3&#xD;
&#xD;
          -  Have the ability to walk 400 m without physical assistance from a device or another&#xD;
             person&#xD;
&#xD;
          -  Do not have other health conditions (e.g., orthopedic, cardiopulmonary) that impact&#xD;
             the ability to safely participate in a moderately intense gait training program&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The investigators will exclude those patients presenting clinical diagnosis of&#xD;
             dementia.&#xD;
&#xD;
          -  The investigators will exclude those patients presenting conditions (cardiac, renal,&#xD;
             or metabolic) that would pose a risk to their health by exercising.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ignacio Fernandez-Mata</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Puget Sound Health Care System Seattle Division, Seattle, WA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Puget Sound Health Care System Seattle Division, Seattle, WA</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 24, 2018</study_first_submitted>
  <study_first_submitted_qc>July 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 31, 2018</study_first_posted>
  <results_first_submitted>August 11, 2021</results_first_submitted>
  <results_first_submitted_qc>September 28, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">October 27, 2021</results_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>gait</keyword>
  <keyword>exercise</keyword>
  <keyword>cognition</keyword>
  <keyword>genetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>We will not make individual participant data available.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 26, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/95/NCT03607695/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Gait Training</title>
          <description>1 hour walking exercise on a treadmill&#xD;
Gait training: Walking on a treadmill and receiving verbal cues to improve gait quality</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>2 Week</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>10 Week</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Local and institutional restrictions on research enacted due to COVID-19 pandemic</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>16 Week</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Local and institutional restrictions on research enacted due to COVID-19 pandemic</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Gait Training</title>
          <description>1 hour walking exercise on a treadmill&#xD;
Gait training: Walking on a treadmill and receiving verbal cues to improve gait quality</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="19"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.5" spread="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Gait Speed (m/s)</title>
        <description>The investigators will use the APDM Movement Monitoring system to assess gait speed (m/s) during straight-line walking as a measure of gait function.</description>
        <time_frame>measured at baseline, 2 weeks, 10 weeks and 16 weeks</time_frame>
        <population>Three participants did not complete the 16 week (follow-up) visit due to local and institutional restrictions on research implemented early in the COVID-19 pandemic.</population>
        <group_list>
          <group group_id="O1">
            <title>Gait Training</title>
            <description>1 hour walking exercise on a treadmill&#xD;
Gait training: Walking on a treadmill and receiving verbal cues to improve gait quality</description>
          </group>
        </group_list>
        <measure>
          <title>Gait Speed (m/s)</title>
          <description>The investigators will use the APDM Movement Monitoring system to assess gait speed (m/s) during straight-line walking as a measure of gait function.</description>
          <population>Three participants did not complete the 16 week (follow-up) visit due to local and institutional restrictions on research implemented early in the COVID-19 pandemic.</population>
          <units>m/s</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.14" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 week</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.21" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 week</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.22" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>16 week</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.20" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Montreal Cognitive Assessment Score</title>
        <description>The investigators will use the Montreal Cognitive Assessment (MoCA; score range=0-30, with 30 indicating better cognitive function) as a reflection of global cognitive function</description>
        <time_frame>measured at baseline and at 10 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gait Training</title>
            <description>1 hour walking exercise on a treadmill&#xD;
Gait training: Walking on a treadmill and receiving verbal cues to improve gait quality</description>
          </group>
        </group_list>
        <measure>
          <title>Montreal Cognitive Assessment Score</title>
          <description>The investigators will use the Montreal Cognitive Assessment (MoCA; score range=0-30, with 30 indicating better cognitive function) as a reflection of global cognitive function</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.1" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 10</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.7" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>16 weeks (study duration)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Gait Training</title>
          <description>1 hour walking exercise on a treadmill&#xD;
Gait training: Walking on a treadmill and receiving verbal cues to improve gait quality</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fall (outside of study visit)</sub_title>
                <description>Fall reported outside of study visits</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="19"/>
              </event>
              <event>
                <sub_title>Lightheadedness</sub_title>
                <description>Hypotensive episode after study visit</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Exercise-associated pain, fatigue</sub_title>
                <description>Muscle pain, joint pain, fatigue after intervention session</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>This trial was impacted by local and institutional restrictions on research implemented during the start of the COVID-19 pandemic. Restrictions on research activities impacted recruitment and impacted data collection for some participants.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Valerie E. Kelly, PT, PhD</name_or_title>
      <organization>University of Washington</organization>
      <phone>206-598-5350</phone>
      <email>vekelly@uw.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

